Latest Propel Bio Management, LLC Stock Portfolio
$191Million | No. of Holdings #29
Propel Bio Management, LLC Performance
2026 Q2+16.87%
YTD+8.61%
2025+17.61%
About Propel Bio Management, LLC and 13F Hedge Fund Stock Holdings
On 2026-08-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Propel Bio Management, LLC reported an equity portfolio of $191.1 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Propel Bio Management, LLC are PAGP, ACHV, CORT. The fund has invested 16.2% of it's portfolio in PLAINS GP HOLDINGS LP-CL and 13.8% of portfolio in ACHIEVE LIFE SCIENCES INC. <br><br> The fund managers got completely rid off VOR BIOPHARMA INC (VOR), VIRIDIAN THERAPEUTICS INC (VRDN) and OCULIS HOLDING AG stocks. They significantly reduced their stock positions in 4D MOLECULAR THERAPEUTICS IN (FDMT), ABEONA THERAPEUTICS INC (ABEO) and COMPASS PATHWAYS PLC (CMPS). Propel Bio Management, LLC opened new stock positions in IMMUNIC INC (IMUX), SCYNEXIS INC (SCYX) and SILENCE THERAPEUTICS PLC (SLN). The fund showed a lot of confidence in some stocks as they added substantially to LEONABIO INC (ATHA), ARTIVA BIOTHERAPEUTICS IN and PALISADE BIO INC (PALI).
Propel Bio Management, LLC Equity Portfolio Value
Last Reported on: 13 Aug, 2026
$191Million
as of Aug 13, 2026Propel Bio Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Propel Bio Management, LLC made a return of 16.87% in the last quarter. In trailing 12 months, it's portfolio return was 29.17%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| immunic inc | 4,995,590 |
| scynexis inc | 2,211,960 |
| silence therapeutics plc | 2,105,230 |
| sagimet biosciences inc-a | 973,037 |
New stocks bought by Propel Bio Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| leonabio inc | 890 |
| artiva biotherapeutics in | 375 |
| palisade bio inc | 131 |
| aquestive therapeutics in | 102 |
| milestone pharmaceuticals | 80.4 |
| inventiva sa - adr | 76.8 |
| kyverna therapeutics inc | 37.05 |
| phathom pharmaceuticals i | 24.85 |
Additions to existing portfolio by Propel Bio Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| 4d molecular therapeutics in | -33.59 |
| abeona therapeutics inc | -26.08 |
| compass pathways plc | -22.77 |
| celldex therapeutics inc | -21.06 |
| corvus pharmaceuticals inc | -17.96 |
| eyepoint inc | -11.16 |
| delcath systems inc | -11.05 |
| zevra therapeutics inc | -10.22 |
Propel Bio Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| coherus oncology inc | -2,413,390 |
| aldeyra therapeutics inc | -1,234,720 |
| nuvation bio inc | -1,412,680 |
| vor biopharma inc | -5,587,370 |
| kalaris therapeutics inc | -1,721,020 |
| immunic inc | -2,620,260 |
| trevi therapeutics inc | -2,647,060 |
| viridian therapeutics inc | -4,087,730 |
Propel Bio Management, LLC got rid off the above stocks
Sector Distribution
Propel Bio Management, LLC has about 66.2% of it's holdings in Healthcare sector.
- Healthcare
- Others
- Energy
| Sector | % |
|---|---|
| Healthcare | 66.2 |
| Others | 17.7 |
| Energy | 16.2 |
Market Cap. Distribution
Propel Bio Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- MID-CAP
- UNALLOCATED
- MICRO-CAP
- NANO-CAP
| Category | % |
|---|---|
| SMALL-CAP | 46 |
| MID-CAP | 24.4 |
| UNALLOCATED | 17.7 |
| MICRO-CAP | 10 |
| NANO-CAP | 1.9 |
Stocks belong to which Index?
About 20.8% of the stocks held by Propel Bio Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 79.2 |
| RUSSELL 2000 | 20.8 |
Propel Bio Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Propel Bio Management, LLC
Propel Bio Management, LLC has 29 stocks in it's portfolio. About 68.1% of the portfolio is in top 10 stocks. ATHA proved to be the most loss making stock for the portfolio. ACHV was the most profitable stock for Propel Bio Management, LLC last quarter.
$191.09MTotal Value
42.00Positions
13 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Abeona Therapeutics Inc Propel Bio Management, LLC's holding in Abeona Therapeutics Inc over time | 3.18% | 983,070 | $6.08M 3.18% | 26.08%decreased 26.08 percentreduced | |
 Achieve Life Sciences Inc Propel Bio Management, LLC's holding in Achieve Life Sciences Inc over time | 13.79% | 4,034,020 | $26.34M 13.79% | 6.54%increased 6.54 percentadded | |
 Aldeyra Therapeutics Inc Propel Bio Management, LLC's holding in Aldeyra Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Aquestive Therapeutics In Propel Bio Management, LLC's holding in Aquestive Therapeutics In over time | 3.14% | 1,442,400 | $6.00M 3.14% | 102.87%increased 102.87 percentadded | |
 Leonabio Inc Leonabio IncATHA Propel Bio Management, LLC's holding in Leonabio Inc over time | 0.72% | 149,279 | $1.37M 0.72% | 890%increased 890 percentadded | |
 Coherus Oncology Inc Propel Bio Management, LLC's holding in Coherus Oncology Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Celldex Therapeutics Inc Propel Bio Management, LLC's holding in Celldex Therapeutics Inc over time | 2.02% | 103,695 | $3.86M 2.02% | 21.06%decreased 21.06 percentreduced | |
 CMPS Compass Pathways PlcCompass Pathways PlcCMPS | 4.24% | 573,086 | $8.11M 4.24% | 22.77%decreased 22.77 percentreduced | |
 Corcept Therapeutics Inc Propel Bio Management, LLC's holding in Corcept Therapeutics Inc over time | 6.21% | 136,499 | $11.87M 6.21% | 7.66%decreased 7.66 percentreduced | |
 Corvus Pharmaceuticals Inc Propel Bio Management, LLC's holding in Corvus Pharmaceuticals Inc over time | 0.55% | 70,380 | $1.05M 0.55% | 17.96%decreased 17.96 percentreduced | |
 Delcath Systems Inc Propel Bio Management, LLC's holding in Delcath Systems Inc over time | 5.74% | 871,460 | $10.97M 5.74% | 11.05%decreased 11.05 percentreduced | |
 Eyepoint Inc Eyepoint IncEYPT Propel Bio Management, LLC's holding in Eyepoint Inc over time | 1.44% | 191,745 | $2.74M 1.44% | 11.16%decreased 11.16 percentreduced | |
 4d Molecular Therapeutics In Propel Bio Management, LLC's holding in 4d Molecular Therapeutics In over time | 1.76% | 252,654 | $3.36M 1.76% | 33.59%decreased 33.59 percentreduced | |
 Immunic Inc Immunic IncIMUX Propel Bio Management, LLC's holding in Immunic Inc over time | 2.61% | 325,022 | $5.00M 2.61% | Newnew position | |
Immunic Inc Immunic IncIMUX Propel Bio Management, LLC's holding in Immunic Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 IVA Inventiva Sa - AdrInventiva Sa - AdrIVA | 2.53% | 1,281,210 | $4.84M 2.53% | 76.8%increased 76.8 percentadded | |
 Milestone Pharmaceuticals Propel Bio Management, LLC's holding in Milestone Pharmaceuticals over time | 5.21% | 7,429,590 | $9.96M 5.21% | 80.4%increased 80.4 percentadded | |
 Nuvation Bio Inc Nuvation Bio IncNUVB Propel Bio Management, LLC's holding in Nuvation Bio Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Ocular Therapeutix Inc Propel Bio Management, LLC's holding in Ocular Therapeutix Inc over time | 1.84% | 357,966 | $3.52M 1.84% | 6.38%decreased 6.38 percentreduced | |
 Ovid Therapeutics Inc Propel Bio Management, LLC's holding in Ovid Therapeutics Inc over time | 1.57% | 1,115,540 | $3.00M 1.57% | 21.06%increased 21.06 percentadded | |